Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) COGS-to-Revenue : 0.33 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Yichang HEC ChangJiang Pharmaceutical Co COGS-to-Revenue?

Yichang HEC ChangJiang Pharmaceutical Co's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$453 Mil. Its Revenue for the six months ended in Dec. 2024 was HK$1,355 Mil.

Yichang HEC ChangJiang Pharmaceutical Co's COGS to Revenue for the six months ended in Dec. 2024 was 0.33.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Yichang HEC ChangJiang Pharmaceutical Co's Gross Margin % for the six months ended in Dec. 2024 was 66.57%.

Yichang HEC ChangJiang Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Yichang HEC ChangJiang Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yichang HEC ChangJiang Pharmaceutical Co COGS-to-Revenue Chart

Yichang HEC ChangJiang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.15

0.47

0.24

0.21

0.25

Yichang HEC ChangJiang Pharmaceutical Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															0.23	0.20	0.22	0.21	0.33

Yichang HEC ChangJiang Pharmaceutical Co COGS-to-Revenue Calculation

Yichang HEC ChangJiang Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	992.641	/	3975.779
	=	0.25

Yichang HEC ChangJiang Pharmaceutical Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	452.901	/	1354.898
	=	0.33

Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Yichang HEC ChangJiang Pharmaceutical Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	452.901 / 1354.898
	=	66.57 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Yichang HEC ChangJiang Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yichang HEC ChangJiang Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yichang HEC ChangJiang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yichang HEC ChangJiang Pharmaceutical Co Ltd (HKSE:01558) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 38 Binjiang Road, Yidu, Hubei Province, Yichang, CHN

Website

http://www.hec-changjiang.com

Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic, and cardiovascular diseases. The company's key revenue driver is the anti-viral product division, which manufactures its key product. Its products include Kewei, Ertongshu, Xinhaining, Oumeining, and Xining.

Executives

Shao Guan Xin Yu Neng Shi Ye Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Xiang Gang Dong Yang Guang Xiao Shou You Xian Gong Si	2101 Beneficial owner
Shen Zhen Shi Dong Yang Guang Shi Ye Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Guang Dong Dong Yang Guang Yao Ye Gu Fen You Xian Gong Si	2101 Beneficial owner
Ru Yuan Yao Zu Zi Zhi Xian Xin Jing Ke Ji Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Ru Yuan Yao Zu Zi Zhi Xian Yu Neng Dian Zi Shi Ye You Xian Gong Si	2201 Interest of corporation controlled by you
Guo Meilan	2201 Interest of corporation controlled by you
Hua Xiaoyi	2201 Interest of corporation controlled by you
Zhang Yushuai	2201 Interest of corporation controlled by you
Blackstone Dawn Pte. Ltd.	2101 Beneficial owner
Blackstone Tactical Opportunities Management Associates (cayman) – Nq L.p.	2201 Interest of corporation controlled by you
Blackstone Inc.	2201 Interest of corporation controlled by you
Btof (dawn Feeder) (cayman) – Nq L.p.	2201 Interest of corporation controlled by you
Blackstone Tactical Opportunities Management Associates Iii (cayman) – Nq L.p.	2201 Interest of corporation controlled by you
Blackstone Tactical Opportunities Lr Associates (cayman) – Nq Ltd.	2201 Interest of corporation controlled by you

Yichang HEC ChangJiang Pharmaceutical Co Headlines

No Headlines